FDA Limits COVID Vaccine Access to Seniors, High-Risk Groups

FDA Limits COVID Vaccine Access to Seniors, and High-Risk Groups

Published AUG 28 2025

FDA Limits COVID Vaccine Access to Seniors, High-Risk Groups

story

Image credit: Unsplash

The Spin

LimitingThese vaccinenew accessrestrictions putsfinally millionsbring ofcommon livessense atto unnecessaryCOVID riskvaccine andpolicy ignoresafter establishedyears scienceof aboutgovernment COVID preventionoverreach. MedicalThe organizationsdata likeclearly theshows Americanyounger, Academyhealthy ofpeople Pediatricsface andminimal Infectiousrisk Diseasesfrom SocietyCOVID, stronglyso opposewhy theseforce restrictionsunnecessary becausemedical vaccinesinterventions remainon crucialmillions forof protectingAmericans? vulnerableKennedy's populations,approach includingprioritizes youngthose childrenwho andactually pregnantneed womenprotection whowhile canrespecting passindividual protectionchoice toand infantsmedical freedom.

New York Post

Limiting vaccine access puts millions of lives at unnecessary risk and ignores established science about COVID prevention. Medical organizations like the American Academy of Pediatrics and the Infectious Diseases Society strongly oppose these restrictions because vaccines remain crucial for protecting vulnerable populations, including young children and pregnant women who can pass protection to infants.

CIDRAP

Metaculus Prediction

There's a 50% chance that an intranasal SARS-CoV-2 vaccine will be approved by the U.S. before July 20, 2026, according to the Metaculus prediction community.